Summit Therapeutics Inc. Increase Decrease Through Exercise Of Warrants Equity
Summit Therapeutics Inc. (SMMT) reported Increase Decrease Through Exercise Of Warrants Equity of GBP 10.00 thousand for the 12-month period ending 2018-01-31, per its 20-F filed 2020-04-30.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2020-04-30
- Summit Therapeutics Inc. increase decrease through exercise of warrants equity for the quarter ending 2018-01-31 was 0.00 GBP.
- Summit Therapeutics Inc. increase decrease through exercise of warrants equity for the quarter ending 2017-10-31 was 0.00 GBP.
- Summit Therapeutics Inc. increase decrease through exercise of warrants equity for the quarter ending 2017-07-31 was 0.00 GBP.
- Summit Therapeutics Inc. increase decrease through exercise of warrants equity for the quarter ending 2017-04-30 was 10.00K GBP.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 9 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|---|
| 2018-01-31 | 0.00 GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | 0.00 GBP derived: sum of 2 quarters · filed 2020-04-30 | 0.00 GBP derived: sum of 3 quarters · filed 2020-04-30 | 10.00K GBP 20-F · filed 2020-04-30 |
| 2017-10-31 | 0.00 GBP derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | 0.00 GBP derived: sum of 2 quarters · filed 2018-12-11 | 10.00K GBP 6-K · filed 2018-12-11 | |
| 2017-07-31 | 0.00 GBP derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | 10.00K GBP 6-K · filed 2018-09-20 | ||
| 2017-04-30 | 10.00K GBP 6-K · filed 2018-06-05 | |||
| 2017-01-31 | 107.00K GBP 20-F · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |